Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Hessel

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Human Vaccines|February 21, 2009
From clinical research to vaccination policy: 25 years experience in vaccinologyLuc Hessel
Influenza and Other Respiratory Viruses|July 25, 2009
Pandemic influenza vaccines: meeting the supply, distribution and deployment challengesLuc Hessel,
Bulletin De L'Academie Nationale De Medecine|May 19, 2004
[Mercury in vaccines]Luc Hessel
Vaccine|May 16, 2002
Antibody responses to recombinant hepatitis B vaccinesLuc Hessel, David J West
Tuberculosis (Edinburgh, Scotland)|March 24, 2012
Rational approach to selection and clinical development of TB vaccine candidatesLew Barker, Luc Hessel, Barry Walker
Canadian Bulletin of Medical History = Bulletin Canadien D'Histoire De La Medecine|May 2, 2008
[Influenza, an eternal problem]Stéphane Barry, Luc Hessel, Norbert Gualde
Vaccine|February 21, 2009
Influenza vaccine supply: building long-term sustainabilityNorbert Hehme, Tony Colegate, Bram Palache, et al.
Pediatrics|September 5, 2006
Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of ageLennart Gustafsson, Luc Hessel, Jann Storsaeter, et al.
Vaccine|April 28, 2007
Reply to "Panico MG, Caporale V, Attena F. Adverse events following hexavalent vaccine (Hexavac): knowledge and information sources"Luc Hessel, Fouzia Guenanèche, Luigi R Biasio, et al.
Vaccine|July 13, 2004
Systematic review of the effects of pertussis vaccines in childrenEric Desauziers, Luc Hessel, Michael D Decker, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Human Vaccines|February 21, 2009
From clinical research to vaccination policy: 25 years experience in vaccinologyLuc Hessel
Influenza and Other Respiratory Viruses|July 25, 2009
Pandemic influenza vaccines: meeting the supply, distribution and deployment challengesLuc Hessel,
Bulletin De L'Academie Nationale De Medecine|May 19, 2004
[Mercury in vaccines]Luc Hessel
Vaccine|May 16, 2002
Antibody responses to recombinant hepatitis B vaccinesLuc Hessel, David J West
Tuberculosis (Edinburgh, Scotland)|March 24, 2012
Rational approach to selection and clinical development of TB vaccine candidatesLew Barker, Luc Hessel, Barry Walker
Canadian Bulletin of Medical History = Bulletin Canadien D'Histoire De La Medecine|May 2, 2008
[Influenza, an eternal problem]Stéphane Barry, Luc Hessel, Norbert Gualde
Vaccine|February 21, 2009
Influenza vaccine supply: building long-term sustainabilityNorbert Hehme, Tony Colegate, Bram Palache, et al.
Pediatrics|September 5, 2006
Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of ageLennart Gustafsson, Luc Hessel, Jann Storsaeter, et al.
Vaccine|April 28, 2007
Reply to "Panico MG, Caporale V, Attena F. Adverse events following hexavalent vaccine (Hexavac): knowledge and information sources"Luc Hessel, Fouzia Guenanèche, Luigi R Biasio, et al.
Vaccine|July 13, 2004
Systematic review of the effects of pertussis vaccines in childrenEric Desauziers, Luc Hessel, Michael D Decker, et al.
Pageof 2